Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEPW) Interest Coverage Ratio (2022 - 2025)

Coeptis Therapeutics Holdings has reported Interest Coverage Ratio over the past 4 years, most recently at 18.91 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 18.91 for Q4 2025, up 124.82% from a year ago — trailing twelve months through Dec 2025 was 134.82 (down 183.2% YoY), and the annual figure for FY2025 was 134.82, down 1251.36%.
  • Interest Coverage Ratio for Q4 2025 was 18.91 at Coeptis Therapeutics Holdings, up from 39.56 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for COEPW hit a ceiling of 995.31 in Q4 2023 and a floor of 489.76 in Q1 2024.
  • Median Interest Coverage Ratio over the past 4 years was 71.44 (2024), compared with a mean of 44.48.
  • Peak annual rise in Interest Coverage Ratio hit 215.5% in 2023, while the deepest fall reached 304.33% in 2023.
  • Coeptis Therapeutics Holdings' Interest Coverage Ratio stood at 315.47 in 2022, then soared by 215.5% to 995.31 in 2023, then tumbled by 107.65% to 76.18 in 2024, then skyrocketed by 124.82% to 18.91 in 2025.
  • The last three reported values for Interest Coverage Ratio were 18.91 (Q4 2025), 39.56 (Q3 2025), and 66.7 (Q2 2025) per Business Quant data.